An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay
By: A.D. Ho, H. Verkerke, J.W. Allen, B.J. Saeedi, D. Boyer, J. Owens, S. Shin, M. Horwath, K. Patel, A. Paul, S.-C. Wu, S. Chonat, P. Zerra, C. Lough, J.D. Roback, A. Neish, C.D. Josephson, C.M. Arthur and S.R. Stowell
Paid access
|Mar 2021Authors
A.D. Ho
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta
H. Verkerke
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta
J.W. Allen
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta
B.J. Saeedi
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
D. Boyer
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
J. Owens
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
S. Shin
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
M. Horwath
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
K. Patel
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
A. Paul
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
S.-C. Wu
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
S. Chonat
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
P. Zerra
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
C. Lough
Lifesouth Blood Donation Services, Gainesville, USA
J.D. Roback
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
A. Neish
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
C.D. Josephson
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
C.M. Arthur
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
S.R. Stowell
Center for Transfusion Medicine and Cellular Therapies, and Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Atlanta
DOI: https://doi.org/10.21307/immunohematology-2021-007 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 33 - 43
Published on: Mar 31, 2021
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 A.D. Ho, H. Verkerke, J.W. Allen, B.J. Saeedi, D. Boyer, J. Owens, S. Shin, M. Horwath, K. Patel, A. Paul, S.-C. Wu, S. Chonat, P. Zerra, C. Lough, J.D. Roback, A. Neish, C.D. Josephson, C.M. Arthur, S.R. Stowell, published by American National Red Cross
This work is licensed under the Creative Commons License.